Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Same Day Discharge Following Minimally Invasive Repair of Pectus Excavatum.

Journal of pediatric surgery·2025
Same author

Successful VA ECMO on an adolescent pre-B cell acute lymphoblastic leukemia patient with necrotizing fasciitis from <i>Clostridium septicum</i>.

Archive of clinical cases·2025
Same author

Invited Commentary on: A Report on Testicular Tissue Cryopreservation for Fertility Preservation in Children: Confirmation of Germ Cell Preservation and Few Surgical Complications.

Journal of pediatric surgery·2025
Same author

Computed tomography-guided percutaneous cryoablation of hereditary adrenal pheochromocytoma in three patients.

Journal of pediatric endocrinology & metabolism : JPEM·2024
Same author

Establishing pediatric age-adjusted shock index cut points in trauma patients younger than 1 year.

The journal of trauma and acute care surgery·2024
Same author

Factors Associated With Early Discharge in Pediatric Trauma Patients Transported by Rotor: A Retrospective Analysis.

Air medical journal·2023

Related Experiment Video

Updated: Jun 3, 2026

A Neonatal BALB/c Mouse Model of Necrotizing Enterocolitis
05:39

A Neonatal BALB/c Mouse Model of Necrotizing Enterocolitis

Published on: November 30, 2021

Neutropenic colitis in children.

Frankie B Fike1, Vincent Mortellaro, David Juang

  • 1Department of Surgery, Children's Mercy Hospital, Kansas City, Missouri 64108, USA.

The Journal of Surgical Research
|March 26, 2011
PubMed
Summary

Neutropenic colitis (NC) is uncommon in pediatric cancer patients, occurring in 1.4% of cases. Most children with NC, often linked to leukemia, recover with medical management and have a low mortality rate.

More Related Videos

Assessment of Intestinal Transcytosis of Neonatal Escherichia coli Bacteremia Isolates
08:32

Assessment of Intestinal Transcytosis of Neonatal Escherichia coli Bacteremia Isolates

Published on: February 17, 2023

Related Experiment Videos

Last Updated: Jun 3, 2026

A Neonatal BALB/c Mouse Model of Necrotizing Enterocolitis
05:39

A Neonatal BALB/c Mouse Model of Necrotizing Enterocolitis

Published on: November 30, 2021

Assessment of Intestinal Transcytosis of Neonatal Escherichia coli Bacteremia Isolates
08:32

Assessment of Intestinal Transcytosis of Neonatal Escherichia coli Bacteremia Isolates

Published on: February 17, 2023

Area of Science:

  • Pediatric Oncology
  • Gastroenterology
  • Hematology

Background:

  • Neutropenic colitis (NC), or typhlitis, affects approximately 5% of patients undergoing chemotherapy for malignancy.
  • NC is strongly associated with profound neutropenia, though its exact cause remains unclear.
  • This study reviews 10 years of experience with NC to determine incidence, management, and outcomes in children.

Purpose of the Study:

  • To assess the incidence of neutropenic colitis in children with cancer.
  • To evaluate the management strategies and patient outcomes for NC.
  • To identify factors associated with NC onset and severity.

Main Methods:

  • Retrospective review of hospital records for 1224 pediatric cancer patients.
  • Strict diagnostic criteria for NC included clinical and radiographic findings; appendicitis cases were excluded.
  • Medical management involved bowel rest, IV antibiotics/antifungals; surgery was reserved for clinical deterioration or free air.

Main Results:

  • NC was confirmed in 17 children, representing a 1.4% incidence.
  • Leukemia was the most frequent underlying diagnosis (53%).
  • A sharp decline in absolute neutrophil count (ANC) preceded NC onset; only 12% required surgery with no direct mortality from NC.

Conclusions:

  • Neutropenic colitis is an infrequent complication in pediatric cancer patients, with a 1.4% incidence in this study.
  • Leukemia is the most common associated malignancy.
  • Most pediatric patients with NC can be managed non-surgically, and mortality directly attributed to NC is low.